Evidence map›Paper›PMID 21605660›Full record

ArticleFree radical biology & medicine2011

Vitamin E prevents NRF2 suppression by allergens in asthmatic alveolar macrophages in vivo.

Ryszard Dworski, Wei Han, Timothy S Blackwell, Aimee Hoskins, Michael L Freeman

Abstract read
In one paragraph

Article in Free radical biology & medicine, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 58 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Review
  5. Review
  6. The Role of Vitamins in the Pathogenesis of Asthma.International journal of molecular sciences · 2023
    Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Role of Nrf2 and Its Activators in Respiratory Diseases.Oxidative medicine and cellular longevity · 2019
    Review
  12. Review
  13. Review
  14. Insights on Localized and Systemic Delivery of Redox-Based Therapeutics.Oxidative medicine and cellular longevity · 2018
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Regulation of Nrf2-an update.Free radical biology & medicine · 2014
    Review
  20. Role of impaired Nrf2 activation in the pathogenesis of oxidative stress and inflammation in chronic tubulo-interstitial nephropathy.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Ryszard DworskiDivision of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University, Nashville, TN 37232, USA. ryszard.dworski@vanderbilt.edu
Wei Han
Timothy S Blackwell
Aimee Hoskins
Michael L Freeman
Vanderbilt University · US

Funding

YOHIMBINE AS A MODEL OF ORTHOSTATIC INTOLERANCEM01RR000095 · NCRR · VANDERBILT UNIVERSITY · PI HAAS, DAVID W · 1985 to 2008
$38.3M
Structural Biology Facility CoreP30ES000267 · NIEHS · VANDERBILT UNIVERSITY · PI GUENGERICH, F PETER · 1985 to 2014
$20.3M
Molecular Approaches to Early Detection of Lung CancerR01CA102353 · NCI · VANDERBILT UNIVERSITY · PI MASSION, PIERRE P. · 2005 to 2014
$2.4M
Role of NADPH Oxidase in Regulating InflammationR01AI079253 · NIAID · ROSWELL PARK CANCER INSTITUTE CORP · PI SEGAL, BRAHM H. · 2009 to 2013
$2.1M
Repression of ARE-Mediated Gene ExpressionR01CA115556 · NCI · VANDERBILT UNIVERSITY · PI FREEMAN, MICHAEL L. · 2007 to 2011
$1.7M
Regulation of Nrf2 SignalingR01CA104590 · NCI · VANDERBILT UNIVERSITY · PI FREEMAN, MICHAEL L. · 2005 to 2009
$1.5M
Oxidant Stress and Allergic AsthmaK23HL080030 · NHLBI · VANDERBILT UNIVERSITY · PI DWORSKI, RYSZARD T · 2006 to 2009
$609k
NCI NIH HHS 5R01 CA102353NCI NIH HHS 5R01 CA104590NCI NIH HHS 5R01 CA 115556NCI NIH HHS R01 CA102353NCI NIH HHS R01 CA104590NCI NIH HHS R01 CA115556NCRR NIH HHS M01 RR000095NCRR NIH HHS M01 RR-00095NHLBI NIH HHS K23 HL080030NIAID NIH HHS AI 079253NIEHS NIH HHS P30 ES000267
6 · The paper itself

Abstract

Asthma is a chronic inflammatory airway disease associated with increased generation of reactive oxidant species and disturbed antioxidant defenses. NRF2 is the master transcription factor that regulates the expression of Phase II antioxidant and detoxifying enzymes. Disruption of NRF2 augments oxidative stress and inflammation in a mouse model of asthma, suggesting a protective role for NRF2 in the lungs in vivo. Yet, little is known about the regulation and function of NRF2 in human asthmatics. Using segmental allergen challenge, a well-established experimental model of IgE-mediated asthma exacerbation in human atopic asthmatics, we investigated the effects of a specific allergen and the modulatory role of vitamin E on NRF2 and a NRF2-target gene, superoxide dismutase, in alveolar macrophages recovered from the airways at 24h after allergen instillation in vivo. Allergen-provoked airway inflammation in sensitive asthmatics caused a profound inhibition of macrophage NRF2 activity and superoxide dismutase, rendering them incapable of responding to the NRF2 inducers. Prolonged treatment with high doses of the antioxidant vitamin E lessened this allergen-induced drop in alveolar macrophage NRF2. These results are the first to demonstrate that NRF2 expression in human asthmatics is compromised upon allergen challenge but can be rescued by vitamin E in vivo.

Indexed as

AdultAllergensAsthmaFemaleHumansMacrophages, AlveolarMaleNF-E2-Related Factor 2Vitamin EAllergensNFE2L2 protein, humanNF-E2-Related Factor 2Vitamin E

Identifiers

PMID21605660
PMCPMC3439844
OpenAlexW2064688425

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.